Filing Flows › AbCellera Biologics (ABCL) › Who owns the stock
Who owns AbCellera Biologics (ABCL) stock
134 funds reported AbCellera Biologics (ABCL) shares in their latest 13F filings, worth $939M in all. The largest holder is Baker Bros. Advisors LP ($259M). Last quarter 69 funds added to their stakes and 75 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 33,012,138 | $259M | increase | 2026-06-30 |
| TD Waterhouse Canada | 9,222,005 | $128M | decrease | 2026-09-30 |
| Capital World Investors | 13,588,349 | $107M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 10,437,431 | $81.9M | decrease | 2026-06-30 |
| Bank of America | 6,141,539 | $48.2M | increase | 2026-06-30 |
| UBS AM, a distinct business unit of UBS Asset Management Americas LLC | 4,317,206 | $33.9M | decrease | 2026-06-30 |
| ArrowMark Colorado Holdings LLC | 4,105,095 | $32.2M | unchanged | 2026-06-30 |
| BlackRock | 3,805,309 | $29.9M | decrease | 2026-06-30 |
| Driehaus Capital Management LLC | 2,864,729 | $22.5M | decrease | 2026-06-30 |
| Tudor Investment Corp et Al | 2,063,191 | $16.2M | decrease | 2026-06-30 |
| Marshall Wace, LLP | 1,902,191 | $14.9M | increase | 2026-06-30 |
| UBS Group AG | 1,870,633 | $14.7M | decrease | 2026-06-30 |
| Morgan Stanley | 1,669,014 | $13.1M | decrease | 2026-06-30 |
| Price T Rowe Associates | 1,587,870 | $12.5M | new | 2026-06-30 |
| Citadel Advisors LLC | 1,586,512 | $12.5M | increase | 2026-06-30 |
AbCellera Biologics' latest quarter
AbCellera Biologics, Q2 2026: revenue $4.0M (-76% year over year), net loss $55.4M, operating cash flow $25.9M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ABCL stock?
By the latest 13F filings: Baker Bros. Advisors LP ($259M); TD Waterhouse Canada ($128M); Capital World Investors ($107M); Two Sigma Investments, LP ($81.9M); Bank of America ($48.2M).
What is the short interest in ABCL?
30,934,912 shares were sold short at the 2026-10-15 settlement, -4.81% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.